Zealand Pharma announced the appointment of Utpal Singh as Chief Scientific Officer. Utpal will join the executive team to lead discovery research and translational sciences at Zealand Pharma.
Utpal brings nearly 25 years of pharmaceutical industry experience spanning the full drug discovery and development lifecycle. Most recently, he served as Senior Vice President of Small Molecule Discovery at Eli Lilly and Company, where he led the transformation of the discovery engine by building new capabilities and strategic partnerships to advance a focused portfolio. His team contributed to the discovery of numerous clinical candidates across multiple therapeutic areas.
“We are committed to expanding our world-leading peptide discovery engine to support the next wave of innovation at Zealand – and Utpal’s appointment further strengthens our foundation for growth,” said Adam Steensberg, Chief Executive Officer, Zealand Pharma. “His leadership in design and discovery of life-changing medicines will be instrumental in our mission to develop enduring therapies for patients.”
Utpal Singh, newly appointed Chief Scientific Officer at Zealand Pharma, added, “The recent advances in data science and machine learning integrated with Zealand Pharma’s exceptional peptide discovery and translational expertise can create a powerful engine for drug discovery. Our ambitions are backed by the deep expertise and financial capital needed to drive transformative ideas that address critical patient needs. It’s a great time to invest in discovery research, and I’m eager to collaborate with this world-class team to develop medicines that could reshape the future of obesity and more.”
Utpal began his pharmaceutical career in 2001 with Merck & Co following completion of a postdoctoral fellowship in organic chemistry at the Massachusetts Institute of Technology. He holds a PhD in chemical engineering from The Pennsylvania State University and a BS in chemical engineering from Purdue University.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!